US competitive advantage in medical innovation in jeopardy? EPPC Fellow comments at #PhRMA12 (video)

US competitive advantage in medical innovation in jeopardy? EPPC Fellow comments at #PhRMA12 (video)

04.13.12 | By Christian Clymer

The U.S. is a global leader in medical research and development, but is that leadership role at risk? James Capretta, a Fellow at the Ethics and Public Policy Center (EPPC) focuses on public policy and economic issues with a focus on health-care and entitlement reform and previously served as an Associate Director at the White House Office of Management and Budget (OMB). Listen to what he worries could jeopardize our country's competitive advantage in medical innovation.

More On PhRMA — powered by PhRMApedia